Ownership Submission
|
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
OMB APPROVAL
|
|
OMB Number:3235-0104Expires:January 31, 2005Estimated average burden hours per response...0.5
|
|
|
1. Name and Address of Reporting Person *
|
|
Watson Katelyn
|
|
2. Date of Event Requiring Statement (Month/Day/Year)
2024-04-18
|
3. Issuer Name and Ticker or Trading Symbol
Talkspace, Inc. [TALK]
|
|
(Last)
|
(First)
|
(Middle)
|
|
C/O TALKSPACE, INC. , 2578 BROADWAY #607
|
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
_____ Director
|
_____ 10% Owner
|
|
_____ Officer (give title below)
|
_____ Other (specify below)
|
|
Chief Marketing Officer /
|
|
5. If Amendment, Date Original Filed(Month/Day/Year)
|
(Street)
|
|
NEW YORK
|
NY
|
10025
|
|
6. Individual or Join/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
|
|
Table I - Non-Derivative Securities Beneficially Owned
|
|
|
1.Title of Security
|
2. Amount of Securities Beneficially Owned
|
3. Ownership Form: Direct (D) or Indirect (I)
|
4. Nature of Indirect Beneficial Ownership
|
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
|
2. Date Exercisable and Expiration Date
|
3. Title and Amount of Securities Underlying Derivative Security
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
|
6. Nature of Indirect Beneficial Ownership
|
|
Date Exercisable
|
Expriation Date
|
Title
|
Amount or Number of Shares
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
|
Director
|
10% Owner
|
Officer
|
Other
|
Watson Katelyn
C/O TALKSPACE, INC.
2578 BROADWAY #607
NEW YORK, NY10025
|
|
|
Chief Marketing Officer
|
|
Signatures
|
/s/ John Reilly, Attorney-in-fact for Katelyn Watson
|
2024-06-26
|
|
**Signature of Reporting Person
|
Date
|
Explanation of Responses:
|
(*)
|
If the form is filed by more than one reporting person, see Instruction 5(b)(v).
|
|
(**)
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
|
(1)
|
As of April 18, 2024. 25% of these restricted stock units vested on December 1, 2023, with the remaining portion vesting in three annual installments.
|
|
(2)
|
As of April 18, 2024. 25% of these restricted stock units vested on March 1, 2024, with the remaining portion vesting in quarterly installments.
|
|
(3)
|
As of April 18, 2024. These restricted stock units vest in 16 consecutive quarterly installments commencing on June 1, 2024.
|
|
(4)
|
25% of the stock options vested on March 1, 2024, with the remaining portion vesting in quarterly installments.
|
|
(5)
|
These stock options vest in 16 consecutive quarterly installments commencing on June 1, 2024.
|
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
See Instruction 6 for procedure.Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
